Matches in Nanopublications for { ?s ?p "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP980315.RAV3WHjh65E3UxYetI8WaorzfnLrkM4er2dkbt_Qb2uSk130_assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980315.RAV3WHjh65E3UxYetI8WaorzfnLrkM4er2dkbt_Qb2uSk130_provenance.
- NP646306.RAv-Jf_cikj4eol8B4j5m8Wthngus_sAVDaolVo4mQBBY130_assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646306.RAv-Jf_cikj4eol8B4j5m8Wthngus_sAVDaolVo4mQBBY130_provenance.
- NP646339.RAtH_DrgPgJn3_6atwEyiBdjfHYl6vdQ0uM_SPnPLZrsY130_assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646339.RAtH_DrgPgJn3_6atwEyiBdjfHYl6vdQ0uM_SPnPLZrsY130_provenance.
- NP646513.RA54wDK-gA1kr-l4vN6nTAZC8A6BhitYe2XBnz9GOjoRY130_assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646513.RA54wDK-gA1kr-l4vN6nTAZC8A6BhitYe2XBnz9GOjoRY130_provenance.
- NP980311.RAEAESkkLnI6yB82mXdUnJSTzMHcJWOG9vKyCqvg9npL8130_assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980311.RAEAESkkLnI6yB82mXdUnJSTzMHcJWOG9vKyCqvg9npL8130_provenance.
- NP980312.RAFsUrcpBrX7YBqoPkJ78SgClDmfcOhkj2HZ5QSY2UxFU130_assertion description "[Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980312.RAFsUrcpBrX7YBqoPkJ78SgClDmfcOhkj2HZ5QSY2UxFU130_provenance.